Vollmer R T, Humphrey P A, Swanson P E, Wick M R, Hudson M L
Laboratory Medicine, VA Medical Center, Durham, North Carolina, USA.
Cancer. 1998 Feb 15;82(4):715-23. doi: 10.1002/(sici)1097-0142(19980215)82:4<715::aid-cncr15>3.0.co;2-0.
Although pathologic level of invasion and histologic grade are helpful in predicting the clinical outcome of transitional cell carcinoma of the bladder, they also create uncertainty. Immunohistochemical staining for p53, MIB-1, epidermal growth factor receptor (EGFR), c-erb B-2, and bcl-2 have shown promise as prognostic factors when evaluated singly, although multivariate analyses that include histologic grade and the interactive effects of these markers have not been studied extensively. The authors have initiated a prospective study to determine whether these markers add prognostic information to that provided by level of invasion and histologic grade. This initial report details how these five markers relate to invasion of the bladder after controlling for the effects of histologic grade.
The authors evaluated 229 transitional cell carcinomas in 229 patients using the World Health Organization grading schema and immunohistochemical staining with antigen retrieval for p53, MIB-1, EGFR, c-erb B-2, and bcl-2, and they related these markers to invasion after controlling for grade with a multivariate logistic regression model.
Although Grades 2 and 3 were the most important for predicting invasion, Grade 2 tumors that stained for either MIB-1 or p53 indicated a significantly greater probability of invasion than suggested by grade alone. bcl-2 and p53 had an opposing and interactive effect: when p53 was absent, the presence of bcl-2 implied less probability of invasion; but when both bcl-2 and p53 were present, the protective effect of bcl-2 was no longer observed. Although neither EGFR nor c-erb B-2 were as important as the other three markers in determining the risk of invasion, Grade 3 tumors that stained for one, and especially both, of these markers were less likely to be invasive.
These five markers sort into three interactive pairs: MIB-1 and p53, bcl-2 and p53, and EGFR and c-erb B-2. MIB-1 and p53 together imply a greater probability of invasion. bcl-2 appears to have a dual role, which depends on the presence of accumulated p53. Finally, EGFR and c-erb B-2 related closely to each other and in Grade 3 tumors imply a lesser probability of invasion. It is likely that combinations of markers, or correlations between markers and grades, will yield prognostic information that is more powerful than what histologic grade alone can provide.
尽管病理侵袭水平和组织学分级有助于预测膀胱移行细胞癌的临床结局,但它们也带来了不确定性。单独评估时,p53、MIB-1、表皮生长因子受体(EGFR)、c-erb B-2和bcl-2的免疫组化染色显示有望成为预后因素,不过包含组织学分级以及这些标志物相互作用影响的多因素分析尚未得到广泛研究。作者开展了一项前瞻性研究,以确定这些标志物是否能为侵袭水平和组织学分级所提供的预后信息增添内容。这份初步报告详细阐述了在控制组织学分级影响后,这五种标志物与膀胱侵袭之间的关系。
作者使用世界卫生组织分级方案以及对p53、MIB-1、EGFR、c-erb B-2和bcl-2进行抗原修复的免疫组化染色,对229例患者的229例膀胱移行细胞癌进行了评估,并通过多因素逻辑回归模型在控制分级后将这些标志物与侵袭相关联。
尽管2级和3级对预测侵袭最为重要,但MIB-1或p53染色阳性的2级肿瘤显示出比单纯分级所提示的更高侵袭概率。bcl-2和p53具有相反的相互作用:当不存在p53时,bcl-2的存在意味着侵袭概率较低;但当bcl-2和p53都存在时,bcl-2的保护作用不再明显。尽管在确定侵袭风险方面,EGFR和c-erb B-2都不如其他三种标志物重要,但这两种标志物中一种尤其是两种染色阳性的3级肿瘤侵袭可能性较小。
这五种标志物可分为三个相互作用的对子:MIB-1和p53、bcl-2和p53、EGFR和c-erb B-2。MIB-1和p53共同提示更高的侵袭概率。bcl-2似乎具有双重作用,这取决于累积p53的存在情况。最后,EGFR和c-erb B-2彼此密切相关,在3级肿瘤中提示较低的侵袭概率。标志物的组合或标志物与分级之间的相关性可能会产生比单纯组织学分级更强大的预后信息。